CRISPR Therapeutics AG CRSP Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP) Financials

CRISPR Therapeutics AG (CRSP)

40.97

-1.85

(-4.32%)

Closed 19 March 7:00AM

Delayed by 15 minutes

40.97

0.00

( 0.00% )

Pre Market: 7:02PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-13.437	-22.183	-43.395	8.595	-24.104	16.492	-26.033	-6.869
Return on Equity (%)	-19.908	-32.498	-56.887	10.042	-26.798	18.587	-30.418	-8.174
Return on Invested Capital (%)	-13.204	-33.057	-57.642	10.117	-27.05	18.773	-31.084	-8.364
Operating Margin (%)	-284.043	-162.47	-5263.38	23.242	-48408.345	41.48	-54298.831	-40.603
Net Profit Margin (%)	-448.819	-166.737	-5281.082	23.087	-48520.862	41.276	-54271.703	-41.381
Book Value Per Share	5.852	4.619	7.558	15.451	22.513	31.237	23.942	23.572
Earnings Per Share	-0.584	-1.684	-3.182	1.1	-4.72	4.917	-8.3	-1.923
Cash Per Share	7.944	5.907	8.807	15.527	15.81	12.017	2.705	4.876
Working Capital Per Share	7.507	5.762	8.459	15.307	21.949	29.913	22.11	22.527
Operating Profit Per Share	2.396	1.01	0.06	5.193	0.096	11.99	0.305	5.547
EBIT Per Share	-0.572	-1.641	-3.171	1.107	-4.709	4.941	-8.304	-1.887
EBITDA Per Share	-0.572	-1.641	-3.171	1.107	-4.709	4.941	-8.304	-1.887
Free Cash Flow Per Share	-0.531	-1.566	-3.196	1.132	-4.596	5.747	-8.134	-2.053

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	39.72M	40.59M	51.85M	60.78M	73.92M	76.81M	78.33M	79.87M

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	78.33M	78.68M	79.37M	79.43M	79.87M	84.67M	84.88M	85.34M
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-51.745	N/A	N/A	N/A	-22989.484	N/A	N/A
Net Profit Margin (%)	N/A	-53.065	N/A	N/A	N/A	-23133.135	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	3.51B
Price to Earnings Ratio	-36.07
Price to Sales Ratio	14.93
Price to Cash Ratio	14.23
Price to Book Ratio	2.94
Dividend Yield	-

Share Statistics

Shares Outstanding	85.77M
Average Volume (1 week)	1.4M
Average Volume (1 Month)	1.93M
52 Week Change	-42.37%
52 Week High	75.91
52 Week Low	36.52

More Ratios Coming Soon!

CRISPR Therapeutics

Golden Arrow Merger

Carl Zeiss Meditec AG AKT (PK)

AzurRx BioPharma

Xtract One Technologies

Rubicon Partners

Temenos Group AG Glarus ... (PK)

Seres Therapeutics

Metalex Ventures (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions